Predictors of inadequate bowel preparation (IBP) in colonoscopy include use of Medicaid insurance, low education levels, current tobacco smoking, and Black race, among other factors, according to a ...

Statistics from 2023 on US obesity rates reveal that in every US state, 1 in every 5 people now has obesity, according to data released.

The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.